de Verneuil Vanina
Reporting owner on Forms 3, 4 and 5, CIK 2036234.
de Verneuil Vanina reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| VIR · Vir Biotechnology, Inc.CIK 1706431 | officer (EVP, General Counsel, Corp Sec) | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| VIR · Vir Biotechnology, Inc.Common Stock | 2026-11-03 | S sold | -2,407 | $11.1 | 110,193 | Form 4 |
| VIR · Vir Biotechnology, Inc.Common Stock | 2026-11-02 | S sold | -1,343 | $11.334 | 112,600 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-070025 | Vir Biotechnology, Inc. | 2026-11-04 |